Ownership history in BFSG, LLC · 5 quarters on record
This page tracks every 13F SEC filing in which BFSG, LLC reported a position in CATALYST PHARMACEUTICALS INC (CPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 161,106 | -515 | -0.3% | 0.31% | $3.2M | $19.70 |
| 2025 Q2 | REDUCED | 161,621 | -242 | -0.1% | 0.39% | $3.5M | $21.70 |
| 2025 Q1 | ADDED | 161,863 | +11,733 | +7.8% | 0.48% | $3.9M | $24.25 |
| 2024 Q4 | REDUCED | 150,130 | -797 | -0.5% | 0.37% | $3.1M | $20.87 |
| 2024 Q3 | INITIATED | 150,927 | — | — | 0.35% | $3.0M | $19.88 |
As of 2025 Q4 — sorted by position size